Quality of Life and Surgical Late Effects of Melanoma Treatment
NCT ID: NCT02352623
Last Updated: 2016-05-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
435 participants
OBSERVATIONAL
2015-02-28
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
NCT04778449
Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma
NCT00745862
Melanoma Risk-Reduction Among Patients and Family Members
NCT00510302
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
NCT02296450
Exploratory Prospective of Experienced by Patients in the Surgery of Skin Cancers of the Face in Interventional Dermatology Department
NCT04336371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Health-related quality of life assessing psychological, physical and social well-being
2. Physical long term side effects (lymphoedema, scarring and neuropathic pain)
3. Lymphoedema assessed by clinical examination and DXA scans
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cutaneous melanoma AJCC stage IB-III
Patients treated for cutaneous melanoma (AJCC stage IB-III) will fill out a questionnaire, undergo clinical examination and DXA scan
DXA scan
DXA scan
Clinical examination
Clinical examination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DXA scan
DXA scan
Clinical examination
Clinical examination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least one year follow-up after melanoma surgery
Exclusion Criteria
* Bilateral axilla or groin melanoma surgery
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danish Cancer Society
OTHER
Herlev Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
caroline gjørup
M.D. ph.d. student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline Asirvatham Gjørup, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Plastic Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Plastic Surgery, Herlev Hospital
Herlev, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gjorup CA, Groenvold M, Hendel HW, Dahlstroem K, Drzewiecki KT, Klausen TW, Holmich LR. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema. Eur J Cancer. 2017 Nov;85:122-132. doi: 10.1016/j.ejca.2017.07.052. Epub 2017 Sep 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-4-2014-127
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.